We have previously reported that persistent activation of the Stat3 signaling pathway, by overexpressing constitutively active Stat3C, in lung alveolar type II (AT II) epithelial cells directly induces spontaneous bronchioalveolar adenocarcinoma in CCSP-rtTA/(tetO) 7 -Stat3C bitransgenic mice. 1 The process is initiated by synthesis and induction of proinflammatory cytokines and chemokines in AT II epithelial cells, triggering heightened levels of inflammatory cell infiltration. Subsequent studies showed that persistent activation of Stat3 in AT II epithelial cells is a common phenomenon in inflammation-induced lung tumor animal models, as demonstrated by matrix metalloproteinase 12 (MMP12) and apoptosis inhibitor 6 (Api6) overexpression bitransgenic mouse models. 2-4 These findings suggested that Stat3 plays a critical role in mediating inflammation-induced lung adenocarcinoma formation. In a clinical setting, the expression of Stat3 and the genes it induces are increased in human lung adenocarcinoma and in chronic obstructive pulmonary disease, a disease similar in pulmonary impairment to lung cancer. 5 Both diseases are common in human smokers. A knockin mouse model also shows the enhanced tumorigenic power of the Stat3C molecule in mammary tumors. 6